Clenbuterol plasma concentrations after repeated oral administration and its effects on cardio‐respiratory and blood lactate responses to exercise in healthy Standardbred horses
- 1 September 1991
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 14 (3) , 243-249
- https://doi.org/10.1111/j.1365-2885.1991.tb00833.x
Abstract
To evaluate the effects of clenbuterol on cardio‐respiratory parameters and blood lactate relation to exercise tolerance, experimental horses performed standardized exercise tests on a high‐speed treadmill before and after administration of the drug. Clenbuterol was administered in feed to six healthy Siandardbrecls at a dose rale of 0.8 μg/kg b.wt twice daily for 5.5 days. Each horse was tested twice, without and with a respiratory mask, during two consecutive days. One week elapsed between the baseline tests without drug and the tests with clenbuterol treatment (each horse served as its own control). The results show an unchanged heart rate response to exercise 2 h after the last clenbuterol administration. The blood lactate response and the arterial oxygen tension during exercise did not differ before and after drug treatment. The oxygen uptake as well as pulmonary ventilation relative to the work load performed was essentially unaffected. The arterial pH during exercise was significantly increased (P < 0.05) following clenbuterol treatment. Plasma levels of clenbuterol were maximal 2 h post‐administration with values between 0.45 and 0.75 ng/ml. The plasma half‐life of elimination was 10.4 h (± 2.25 SD). In conclusion, clenbuterol did not cause any major effects on the cardio‐respiratory and blood lactate parameters studied in healthy horses performing submaximal exercise tolerance tests.Keywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics and cardio‐respiratory effects of oral theophylline in exercised horsesJournal of Veterinary Pharmacology and Therapeutics, 1989
- Quantitation of clenbuteral in biological fluids using ammonia CI and automated capillary GCMSJournal of Mass Spectrometry, 1988
- Clinical efficacy of clenbuterol with COPD in horsesJournal of Equine Veterinary Science, 1985
- Effects of clenbuterol hydrochloride on certain respiratory and cardiovascular parameters in horses performing treadmill exerciseResearch in Veterinary Science, 1983
- Cardiopulmonary effects of clenbuterol in the horseJournal of Veterinary Pharmacology and Therapeutics, 1981
- NAB 365, a beta 2‐receptor sympathomimetic agent: clinical experience in horses with lung diseaseJournal of Veterinary Pharmacology and Therapeutics, 1978